As of 2025-08-04, the Relative Valuation of Seelos Therapeutics Inc (SEEL) is 1,001.48 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.28 USD, the upside of Seelos Therapeutics Inc based on Relative Valuation is 78140.4%.
The range of the Relative Valuation is 913.24 - 1,194.96 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 18.7x | 18.1x |
| Forward P/E multiples | 18.0x - 22.8x | 20.2x |
| Fair Price | 913.24 - 1,194.96 | 1,001.48 |
| Upside | 71247.0% - 93256.6% | 78140.4% |
| Date | P/E |